Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
Clinical trial NCT02382406 · TERMINATED
Trial details
- NCT number
- NCT02382406
- Sponsor
- Nisha Mohindra, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-04
- Primary completion
- 2022-04-14
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.